Pelthos Therapeutics to Participate in 2026 Jefferies Global Healthcare Conference
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Pelthos Therapeutics (NYSE American:PTHS) announced that CEO Scott Plesha will present at the 2026 Jefferies Global Healthcare Conference in New York. The presentation is scheduled for 11:05 a.m. ET on June 4, 2026, followed by one-on-one investor meetings arranged through Jefferies representatives.
Details
News Market Reaction – PTHS
On May 29, the first trading day after this news, PTHS closed 2.60% above the previous close.
Data tracked by StockTitan Argus for the May 29 session.
Key Figures
- Conference date
- June 4, 2026
- Jefferies Global Healthcare Conference presentation in New York
- Presentation time
- 11:05 a.m. ET
- Scheduled CEO presentation slot at Jefferies conference
- Conference year
- 2026
- Jefferies Global Healthcare Conference 2026 participation
Historical Context
-
Reported growing ZELSUVMI revenue and narrowed net loss versus prior quarter.
-
Announced timing and access details for upcoming Q1 2026 results call.
-
CEO scheduled for one-on-one investor meetings at Piper Sandler symposium.
-
Appointed new CFO with extensive public company finance experience.
-
First patient dosed in Phase 1b/2a trial of CT2000 for eye pain.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
DURHAM, N.C., May 28, 2026 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs, (“Pelthos”), today announced that CEO Scott Plesha will present at 11:05 am ET and participate in one-on-one investor meetings at the Jefferies Global Healthcare Conference on June 4, 2026 in New York. Investors interested in arranging one-on-one meetings should contact their Jefferies representative.
About Pelthos Therapeutics
Pelthos Therapeutics is a commercial-stage biopharmaceutical company focused on building and advancing a portfolio of differentiated cutaneous infectious disease products that address unmet patient needs. ZELSUVMI® (berdazimer) topical gel,
Contacts
Investors:
LifeSci Advisors, LLC
Mike Moyer, Managing Director
mmoyer@lifesciadvisors.com
Media:
KWM Communications
Kellie Walsh
pelthos@kwmcommunications.com
(914) 315-6072
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.